InterCure Ltd.

NASDAQ: INCR · Real-Time Price · USD
1.66
0.02 (1.22%)
At close: Aug 14, 2025, 3:59 PM
1.63
-1.81%
Pre-market: Aug 15, 2025, 07:16 AM EDT

InterCure Income Statement

Financials in ILS. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
238.84M 355.55M 388.68M 219.68M
Cost of Revenue
208.61M 250.46M 233.6M 128.55M
Gross Profit
30.23M 105.09M 155.08M 91.13M
Operating Income
-67.21M -41.57M 50.63M 28.19M
Interest Income
2.7M 4.55M 844K 130K
Pretax Income
-87.32M -61.28M 43.84M 18.74M
Net Income
-67.8M -61.96M 44.82M 4.69M
Selling & General & Admin
84.63M 86.24M 97.32M 53.94M
Research & Development
414K 388K 632K 1.24M
Other Expenses
12.4M 60.04M 4.2M 2.93M
Operating Expenses
97.44M 146.66M 104.46M 62.95M
Interest Expense
20.64M 24.22M 14.69M 5.04M
Selling & Marketing Expenses
21.71M 21.94M 5.6M 8.16M
Cost & Expenses
306.05M 397.12M 335.75M 191.49M
Income Tax Expense
-14.53M 2.25M 93K 11.44M
Shares Outstanding (Basic)
47.77M 45.56M 45.35M 38.49M
Shares Outstanding (Diluted)
47.77M 45.57M 45.35M 40.84M
EPS (Basic)
-1.42 -1.36 0.99 0.12
EPS (Diluted)
-1.42 -1.36 0.99 0.10
EBITDA
-51.31M -23.9M 70.23M 31.17M
EBIT
-66.68M -37.07M 58.53M 23.78M
Depreciation & Amortization
15.37M 13.17M 11.7M 7.39M